Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

ENTA Enanta Pharmaceuticals Inc

12,76

-0,34 (-2,60%)

09 Mai 2024 - Fermé

Retardé de 15 minutes

Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals

Enanta Pharmaceuticals (NASDAQ:ENTA)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024

Plus de graphiques de la Bourse Enanta Pharmaceuticals

Enanta Pharmaceuticals (NASDAQ:ENTA)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024

Plus de graphiques de la Bourse Enanta Pharmaceuticals

Actualités Enanta Pharmaceuticals Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Mercredi 8 Mai 2024 ( il y a 4 heures) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mercredi 8 Mai 2024 ( il y a 5 heures) • Edgar (US Regulatory)

Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Mardi 7 Mai 2024 ( il y a 2 jours) • Business Wire

Form 8-K - Current report
Lundi 6 Mai 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Lundi 6 Mai 2024 ( il y a 2 jours) • Business Wire

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mardi 30 Avril 2024 ( il y a 1 semaine) • Business Wire

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Mardi 30 Avril 2024 ( il y a 1 semaine) • Business Wire

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Lundi 29 Avril 2024 ( il y a 1 semaine) • Business Wire

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Mercredi 17 Avril 2024 ( il y a 3 semaines) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 8 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 8 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 8 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Enanta Pharmaceuticals Inc

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales